Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users

被引:23
作者
Tucker, T
Fry, CL
Lintzeris, N
Baldwin, S
Ritter, A
Donath, S
Whelan, G
机构
[1] Turning Point Alcohol & Drug Ctr, Fitzroy, Vic 3065, Australia
[2] Univ Melbourne, Dept Publ Hlth, Parkville, Vic 3052, Australia
[3] Natl Addict Ctr, London, England
[4] Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia
[5] St Vincents Hosp, Melbourne, Vic, Australia
关键词
brief behavioural intervention; hepatitis C virus; injecting drug use; randomized controlled trial;
D O I
10.1111/j.1360-0443.2004.00809.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aim To develop and evaluate a brief intervention for reducing risk behaviours associated with HCV transmission in injecting drug users (IDU). Design Randomized controlled trial of an individually tailored brief behavioural intervention (BBI) (experimental) versus a standardized educational intervention (control). Setting Specialist drug treatment facility in Melbourne, Australia. Participants One hundred and forty-five IDU (aged 18 or over, injecting at least weekly in the preceding 6 months) recruited and randomized to the experimental condition (n = 73) or the control condition (n = 72). Interventions The BBI was based on the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ)-a standardized blood-borne virus risk assessment instrument comprising injecting risk, sexual risk and other skin penetration risk subscales. The BBV-TRAQ was used to identify individual HCV risk practices and to tailor the 30-minute experimental BBI. Control participants received a standardized HCV educational session, using current educational materials. Main outcome measures BBV-TRAQ subscale and total scores and measures of participant satisfaction. Results One hundred and twenty-four participants (86%) were followed-up at 4 weeks ( 7 days). Analyses revealed a significant reduction in HCV risk behaviours for both groups at 1-month follow-up, with participants in the experimental BBI condition reporting higher overall satisfaction with the intervention compared to the control group. Conclusions Both groups reported significant reductions in risk behaviour, indicating that while BBI methods hold promise for HCV education and prevention, they were not demonstrated to be more effective than the provision of standard educational materials. Future research could evaluate the efficacy of the BBV-TRAQ as a risk behaviour intervention and counselling tool in clinical, NSP and peer education settings.
引用
收藏
页码:1157 / 1166
页数:10
相关论文
共 50 条
[41]   Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia [J].
Maher, Lisa ;
Li, Jiong ;
Jalaludin, Bin ;
Wand, Handan ;
Jayasuriya, Rohan ;
Dixon, David ;
Kaldor, John M. .
DRUG AND ALCOHOL DEPENDENCE, 2007, 89 (2-3) :244-250
[42]   Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia [J].
Maher, L ;
Chant, K ;
Jalaludin, B ;
Sargent, P .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (10) :1114-1120
[43]   Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning [J].
Wand, Handan ;
Spiegelman, Donna ;
Law, Matthew ;
Jalaludin, Bin ;
Kaldor, John ;
Maher, Lisa .
ADDICTION, 2009, 104 (12) :2049-2056
[44]   The Australian Study of HIV and Injecting Drug Use .1. Prevalence for HIV, hepatitis B and hepatitis C among injecting drug users in four Australian cities [J].
Loxley, WM ;
Phillips, M ;
Carruthers, SJ ;
Bevan, JS .
DRUG AND ALCOHOL REVIEW, 1997, 16 (03) :207-214
[45]   Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C [J].
Alavi, Maryam ;
Spelman, Tim ;
Matthews, Gail V. ;
Haber, Paul S. ;
Day, Carolyn ;
van Beek, Ingrid ;
Walsh, Nick ;
Yeung, Barbara ;
Bruneau, Julie ;
Petoumenos, Kathy ;
Dolan, Kate ;
Kaldor, John M. ;
Dore, Gregory J. ;
Hellard, Margaret ;
Grebely, Jason .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 (10) :976-983
[46]   A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users [J].
Garfein, Richard S. ;
Golub, Elizabeth T. ;
Greenberg, Alan E. ;
Hagan, Holly ;
Hanson, Debra L. ;
Hudson, Sharon M. ;
Kapadia, Farzana ;
Latka, Mary H. ;
Ouellet, Lawrence. ;
Purcell, David W. ;
Strathdee, Steffanie A. ;
Thiede, Hanne .
AIDS, 2007, 21 (14) :1923-1932
[47]   Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: Increased risk following diagnosis with hepatitis C infection [J].
McDonald, Scott A. ;
Hutchinson, Sharon J. ;
Bird, Sheila M. ;
Robertson, Chris ;
Mills, Peter R. ;
Dillon, John F. ;
Goldberg, David J. .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2011, 22 (01) :63-69
[48]   Identification and phylogenetic analysis of hepatitis C virus in forensic blood samples obtained from injecting drug users [J].
Kato, H. ;
Maeno, Y. ;
Seko-Nakamura, Y. ;
Monma-Ohtaki, J. ;
Sugiura, S. ;
Takahashi, K. ;
Zhe, L. X. ;
Matsumoto, T. ;
Kurvanov, F. ;
Mizokami, M. ;
Nagao, M. .
FORENSIC SCIENCE INTERNATIONAL, 2007, 168 (01) :27-33
[49]   Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users [J].
Mathei, C. ;
Shkedy, Z. ;
Denis, B. ;
Kabali, C. ;
Aerts, M. ;
Molenberghs, G. ;
Van Damme, P. ;
Buntinx, F. .
JOURNAL OF VIRAL HEPATITIS, 2006, 13 (08) :560-570
[50]   Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands [J].
van de Laar, TJW ;
Langendam, MW ;
Bruisten, SM ;
Welp, EAE ;
Verhaest, I ;
van Ameijden, EJC ;
Coutinho, RA ;
Prins, M .
JOURNAL OF MEDICAL VIROLOGY, 2005, 77 (04) :509-518